skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 87,940  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Research & Development remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective
Material Type:
Article
Add to My Research

Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective

Clinical and translational science, 2018-01, Vol.11 (1), p.21-27 [Peer Reviewed Journal]

2017 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics ;2018. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1752-8054 ;EISSN: 1752-8062 ;DOI: 10.1111/cts.12500 ;PMID: 28796445

Full text available

2
Knowledge translation in health: how implementation science could contribute more
Material Type:
Article
Add to My Research

Knowledge translation in health: how implementation science could contribute more

BMC medicine, 2019-05, Vol.17 (1), p.88-88, Article 88 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-019-1322-9 ;PMID: 31064388

Full text available

3
The Structure of Clinical Translation: Efficiency, Information, and Ethics
Material Type:
Article
Add to My Research

The Structure of Clinical Translation: Efficiency, Information, and Ethics

The Hastings Center report, 2015-03, Vol.45 (2), p.27-39 [Peer Reviewed Journal]

2015 The Hastings Center ;Copyright Blackwell Publishing Ltd. Mar-Apr 2015 ;ISSN: 0093-0334 ;EISSN: 1552-146X ;DOI: 10.1002/hast.433 ;PMID: 25628068 ;CODEN: HSCRAS

Full text available

4
Asia's Ascent — Global Trends in Biomedical R&D Expenditures
Material Type:
Article
Add to My Research

Asia's Ascent — Global Trends in Biomedical R&D Expenditures

The New England journal of medicine, 2014-01, Vol.370 (1), p.3-6 [Peer Reviewed Journal]

Copyright © 2014 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1311068 ;PMID: 24382062

Full text available

5
Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19
Material Type:
Article
Add to My Research

Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19

PLoS pathogens, 2020-10, Vol.16 (10), p.e1008902-e1008902 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Kinsella et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Kinsella et al 2020 Kinsella et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1008902 ;PMID: 33035262

Full text available

6
Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons
Material Type:
Article
Add to My Research

Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons

Neuron (Cambridge, Mass.), 2018-11, Vol.100 (4), p.783-797 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Nov 21, 2018 ;ISSN: 0896-6273 ;EISSN: 1097-4199 ;DOI: 10.1016/j.neuron.2018.10.033 ;PMID: 30465765

Full text available

7
How to strengthen a health research system: WHO's review, whose literature and who is providing leadership?
Material Type:
Article
Add to My Research

How to strengthen a health research system: WHO's review, whose literature and who is providing leadership?

Health research policy and systems, 2020-06, Vol.18 (1), p.72-72, Article 72 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1478-4505 ;EISSN: 1478-4505 ;DOI: 10.1186/s12961-020-00581-1 ;PMID: 32571364

Full text available

8
Global cancer research in the post-pandemic world
Material Type:
Article
Add to My Research

Global cancer research in the post-pandemic world

The lancet oncology, 2021-12, Vol.22 (12), p.1652-1654 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00602-1 ;PMID: 34856137

Full text available

9
The COVID-19 Innovation System
Material Type:
Article
Add to My Research

The COVID-19 Innovation System

Health affairs (Millwood, Va.), 2021-03, Vol.40 (3), p.400-5 [Peer Reviewed Journal]

Copyright The People to People Health Foundation, Inc., Project HOPE Mar 2021 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2020.02097 ;PMID: 33539184

Full text available

10
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
Material Type:
Article
Add to My Research

The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors

Nature reviews. Drug discovery, 2018-11, Vol.17 (12), p.854-855 [Peer Reviewed Journal]

Copyright Nature Publishing Group Dec 2018 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2018.210

Full text available

11
Reboot biomedical R&D in the global public interest
Material Type:
Article
Add to My Research

Reboot biomedical R&D in the global public interest

Nature (London), 2022-02, Vol.602 (7896), p.207-210 [Peer Reviewed Journal]

Copyright Nature Publishing Group Feb 10, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-022-00324-y ;PMID: 35140380

Full text available

12
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
Material Type:
Article
Add to My Research

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination

New England Journal of Medicine, 2022-03, Vol.386 (11), p.1088-1091 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119912 ;PMID: 35081298

Digital Resources/Online E-Resources

13
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
Material Type:
Article
Add to My Research

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI

The New England journal of medicine, 2019-10, Vol.381 (17), p.1621-1631 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1907096

Full text available

14
Measuring research impact in Australia's medical research institutes: a scoping literature review of the objectives for and an assessment of the capabilities of research impact assessment frameworks
Material Type:
Article
Add to My Research

Measuring research impact in Australia's medical research institutes: a scoping literature review of the objectives for and an assessment of the capabilities of research impact assessment frameworks

Health research policy and systems, 2017-03, Vol.15 (1), p.22-22, Article 22 [Peer Reviewed Journal]

Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1478-4505 ;EISSN: 1478-4505 ;DOI: 10.1186/s12961-017-0180-1 ;PMID: 28327199

Full text available

15
A systematic screen of FDA-approved drugs for inhibitors of biological threat agents
Material Type:
Article
Add to My Research

A systematic screen of FDA-approved drugs for inhibitors of biological threat agents

PloS one, 2013-04, Vol.8 (4), p.e60579-e60579 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Madrid et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Madrid et al 2013 Madrid et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0060579 ;PMID: 23577127

Full text available

16
Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry
Material Type:
Article
Add to My Research

Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry

PloS one, 2012-06, Vol.7 (6), p.e39198-e39198 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Van Remoortel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Van Remoortel et al. 2012 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0039198 ;PMID: 22745715

Full text available

17
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation
Material Type:
Article
Add to My Research

Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation

BMC biology, 2012-03, Vol.10 (1), p.29-29, Article 29 [Peer Reviewed Journal]

COPYRIGHT 2012 BioMed Central Ltd. ;COPYRIGHT 2012 BioMed Central Ltd. ;2012 Vinci et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2012 Vinci et al; licensee BioMed Central Ltd. 2012 Vinci et al; licensee BioMed Central Ltd. ;ISSN: 1741-7007 ;EISSN: 1741-7007 ;DOI: 10.1186/1741-7007-10-29 ;PMID: 22439642

Full text available

18
Resource allocation for biomedical research: analysis of investments by major funders
Material Type:
Article
Add to My Research

Resource allocation for biomedical research: analysis of investments by major funders

Health research policy and systems, 2020-02, Vol.18 (1), p.20-20, Article 20 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2020 ;ISSN: 1478-4505 ;EISSN: 1478-4505 ;DOI: 10.1186/s12961-020-0532-0 ;PMID: 32066463

Full text available

19
Artificial intelligence foundation for therapeutic science
Material Type:
Article
Add to My Research

Artificial intelligence foundation for therapeutic science

Nature chemical biology, 2022-10, Vol.18 (10), p.1033-1036 [Peer Reviewed Journal]

Springer Nature America, Inc. 2022. ;ISSN: 1552-4450 ;EISSN: 1552-4469 ;DOI: 10.1038/s41589-022-01131-2 ;PMID: 36131149

Full text available

20
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
Material Type:
Article
Add to My Research

Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer

Immunity (Cambridge, Mass.), 2019-02, Vol.50 (2), p.302-316 [Peer Reviewed Journal]

2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Feb 19, 2019 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2019.01.020 ;PMID: 30784578

Full text available

Results 1 - 20 of 87,940  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1982  (18)
  2. 1982 To 1991  (168)
  3. 1992 To 2001  (1,380)
  4. 2002 To 2012  (13,669)
  5. After 2012  (72,707)
  6. More options open sub menu

Subject 

  1. R&d  (87,897)
  2. Medical Research  (84,638)
  3. Biotechnology Industry  (22,237)
  4. Earnings Per Share  (17,015)
  5. Stockholders  (14,093)
  6. Pharmaceutical Industry  (13,382)
  7. Stock Exchanges  (13,291)
  8. Clinical Trials  (12,400)
  9. Cancer  (11,857)
  10. Coronaviruses  (11,559)
  11. Covid-19  (10,760)
  12. Net Losses  (9,986)
  13. Collaboration  (9,927)
  14. Oncology  (8,674)
  15. Cancer Therapies  (7,335)
  16. Patients  (6,822)
  17. Corporate Profits  (6,699)
  18. Pandemics  (6,121)
  19. Investments  (6,048)
  20. More options open sub menu

Language 

  1. English  (87,916)
  2. Japanese  (525)
  3. French  (25)
  4. Urdu  (23)
  5. Portuguese  (23)
  6. Spanish  (14)
  7. Norwegian  (12)
  8. German  (11)
  9. Chinese  (4)
  10. Hindi  (3)
  11. Russian  (1)
  12. Italian  (1)
  13. Romanian  (1)
  14. Turkish  (1)
  15. Croatian  (1)
  16. Dutch  (1)
  17. More options open sub menu

Searching Remote Databases, Please Wait